Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the ALWP of the EBMT
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Biology of Blood and Marrow Transplantation, 26, 3, S. S8-S9
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2020
- Ereignis
-
Veröffentlichung
- (wo)
-
Amsterdam
- (wer)
-
Elsevier BV
- (wann)
-
2020
- Urheber
-
Waidhauser, Johanna
Labopin, Myriam
Esteve, Jordi
Kröger, Nicolaus
Cornelissen, Jan
Gedde-Dahl, Tobias
Van Gorkom, Gwendolyn
Finke, Jürgen
Rovira, Montserrat
Schaap, Nicolaas
Petersen, Eefke
Beelen, Dietrich W.
Bunjes, Donald W.
Schmid, Christoph
Nagler, Arnon
Mohty, Mohamad
- DOI
-
10.1016/j.bbmt.2019.12.072
- URN
-
urn:nbn:de:bvb:384-opus4-983353
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:39 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Waidhauser, Johanna
- Labopin, Myriam
- Esteve, Jordi
- Kröger, Nicolaus
- Cornelissen, Jan
- Gedde-Dahl, Tobias
- Van Gorkom, Gwendolyn
- Finke, Jürgen
- Rovira, Montserrat
- Schaap, Nicolaas
- Petersen, Eefke
- Beelen, Dietrich W.
- Bunjes, Donald W.
- Schmid, Christoph
- Nagler, Arnon
- Mohty, Mohamad
- Universität Augsburg
- Elsevier BV
Entstanden
- 2020
Ähnliche Objekte (12)
Allogeneic transplant for mixed phenotype acute leukemia (MPAL): characteristics and outcome in the ALWP-EBMT Database
Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT
Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT
Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT
Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT
Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT
Secondary AML is an independent risk factor for outcome after SCT in First complete remission: a registry-based comparison to de novo AML on behalf of the EBMT acute leukemia working party
Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMT
Predictive limitations of hematopoietic stem cell transplantation associated mortality: a machine learning in-silico analysis of the EBMT - Acute Leukemia Working Party Registry
Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT
Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT
Allogeneic transplant for mixed phenotype acute leukemia (MPAL): characteristics and outcome in the ALWP-EBMT Database
Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT
Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT
Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT
Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT
Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT
Secondary AML is an independent risk factor for outcome after SCT in First complete remission: a registry-based comparison to de novo AML on behalf of the EBMT acute leukemia working party
Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMT
Predictive limitations of hematopoietic stem cell transplantation associated mortality: a machine learning in-silico analysis of the EBMT - Acute Leukemia Working Party Registry
Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT
Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT
Allogeneic transplant for mixed phenotype acute leukemia (MPAL): characteristics and outcome in the ALWP-EBMT Database
Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT
Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT
Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT
Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT
Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT
Secondary AML is an independent risk factor for outcome after SCT in First complete remission: a registry-based comparison to de novo AML on behalf of the EBMT acute leukemia working party
Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMT
Predictive limitations of hematopoietic stem cell transplantation associated mortality: a machine learning in-silico analysis of the EBMT - Acute Leukemia Working Party Registry
Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT